利用下一代测序技术检测胃癌患者BRCA1和BRCA2基因组变异

IF 1.7 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
American journal of translational research Pub Date : 2024-12-15 eCollection Date: 2024-01-01 DOI:10.62347/MRIE2131
Fangfang Li, Mostafa A Abdel-Maksoud, Tahir Ullah, Moeen Ul Haq, Abdurrehman Khan, Aliu Olalekan Olatunji, Bakar Bin Khatab Abbasi, Ibrahim A Saleh, Mehak Nabi Rather, Jehad S Al-Hawadi, Naser Zomot, Saeedah Musaed Almutairi, Rida Naz
{"title":"利用下一代测序技术检测胃癌患者BRCA1和BRCA2基因组变异","authors":"Fangfang Li, Mostafa A Abdel-Maksoud, Tahir Ullah, Moeen Ul Haq, Abdurrehman Khan, Aliu Olalekan Olatunji, Bakar Bin Khatab Abbasi, Ibrahim A Saleh, Mehak Nabi Rather, Jehad S Al-Hawadi, Naser Zomot, Saeedah Musaed Almutairi, Rida Naz","doi":"10.62347/MRIE2131","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To explore the landscape of BRCA1/2 mutations in gastric cancer patients.</p><p><strong>Methods: </strong>Next-generation sequencing (NGS), Sanger sequencing, reverse transcription quantitative polymerase chain reaction (RT-qPCR), Immunohistochemistry, The Cancer Genome Atlas (TCGA), gnomAD, and DAVID.</p><p><strong>Results: </strong>With 95% of bases boasting a phred score surpassing 30 and a minimum coverage depth of 500X, our NGS approach ensures high-quality data acquisition. Analyzing BRCA1 and BRCA2 sequences revealed 11 and 4 mutations, respectively, with one pathogenic mutation identified in each gene. This emphasizes the prominence of BRCA1 mutations in gastric cancer. Sanger sequencing validation confirmed the presence of pathogenic mutations in select cases, consolidating our findings. Frequency analysis utilizing the gnomAD database elucidated the rarity of these mutations in the Asian population, underscoring their uniqueness. Exploring TCGA data further corroborated this rarity, emphasizing the distinctive nature of these mutations in gastric cancer. RT-qPCR analysis unveiled a significant reduction in BRCA1/2 expression in samples harboring pathogenic mutations, hinting at their potential role in down-regulating gene expression. Immunohistochemistry confirmed diminished protein expression in samples with pathogenic mutations, solidifying our observations. Kaplan-Meier survival analysis demonstrated significantly poorer survival outcomes for patients with pathogenic BRCA1/2 mutations compared to those without, emphasizing their potential role in prognosis. Additionally, KEGG pathway analysis highlighted the involvement of BRCA1/2 in critical cancer-associated pathways, emphasizing their role in tumorigenesis.</p><p><strong>Conclusion: </strong>Our comprehensive findings underscore the clinical significance of BRCA1/2 mutations in gastric cancer, advocating for further research to elucidate their mechanistic implications and therapeutic opportunities.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"16 12","pages":"7898-7910"},"PeriodicalIF":1.7000,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733335/pdf/","citationCount":"0","resultStr":"{\"title\":\"Detection of genomic variants in BRCA1 and BRCA2 across gastric cancer patients using next generation sequencing.\",\"authors\":\"Fangfang Li, Mostafa A Abdel-Maksoud, Tahir Ullah, Moeen Ul Haq, Abdurrehman Khan, Aliu Olalekan Olatunji, Bakar Bin Khatab Abbasi, Ibrahim A Saleh, Mehak Nabi Rather, Jehad S Al-Hawadi, Naser Zomot, Saeedah Musaed Almutairi, Rida Naz\",\"doi\":\"10.62347/MRIE2131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To explore the landscape of BRCA1/2 mutations in gastric cancer patients.</p><p><strong>Methods: </strong>Next-generation sequencing (NGS), Sanger sequencing, reverse transcription quantitative polymerase chain reaction (RT-qPCR), Immunohistochemistry, The Cancer Genome Atlas (TCGA), gnomAD, and DAVID.</p><p><strong>Results: </strong>With 95% of bases boasting a phred score surpassing 30 and a minimum coverage depth of 500X, our NGS approach ensures high-quality data acquisition. Analyzing BRCA1 and BRCA2 sequences revealed 11 and 4 mutations, respectively, with one pathogenic mutation identified in each gene. This emphasizes the prominence of BRCA1 mutations in gastric cancer. Sanger sequencing validation confirmed the presence of pathogenic mutations in select cases, consolidating our findings. Frequency analysis utilizing the gnomAD database elucidated the rarity of these mutations in the Asian population, underscoring their uniqueness. Exploring TCGA data further corroborated this rarity, emphasizing the distinctive nature of these mutations in gastric cancer. RT-qPCR analysis unveiled a significant reduction in BRCA1/2 expression in samples harboring pathogenic mutations, hinting at their potential role in down-regulating gene expression. Immunohistochemistry confirmed diminished protein expression in samples with pathogenic mutations, solidifying our observations. Kaplan-Meier survival analysis demonstrated significantly poorer survival outcomes for patients with pathogenic BRCA1/2 mutations compared to those without, emphasizing their potential role in prognosis. Additionally, KEGG pathway analysis highlighted the involvement of BRCA1/2 in critical cancer-associated pathways, emphasizing their role in tumorigenesis.</p><p><strong>Conclusion: </strong>Our comprehensive findings underscore the clinical significance of BRCA1/2 mutations in gastric cancer, advocating for further research to elucidate their mechanistic implications and therapeutic opportunities.</p>\",\"PeriodicalId\":7731,\"journal\":{\"name\":\"American journal of translational research\",\"volume\":\"16 12\",\"pages\":\"7898-7910\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733335/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of translational research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.62347/MRIE2131\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of translational research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.62347/MRIE2131","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨胃癌患者BRCA1/2基因突变情况。方法:新一代测序(NGS)、Sanger测序、逆转录定量聚合酶链反应(RT-qPCR)、免疫组织化学、癌症基因组图谱(TCGA)、gnomAD、DAVID。结果:95%的基地的phred得分超过30分,最低覆盖深度为500X,我们的NGS方法确保了高质量的数据采集。分析BRCA1和BRCA2序列,分别发现11个和4个突变,每个基因鉴定出一个致病突变。这强调了BRCA1突变在胃癌中的重要性。Sanger测序验证证实了某些病例中致病性突变的存在,巩固了我们的发现。利用gnomAD数据库的频率分析阐明了这些突变在亚洲人群中的罕见性,强调了它们的独特性。探索TCGA数据进一步证实了这种罕见性,强调了这些突变在胃癌中的独特性质。RT-qPCR分析显示,BRCA1/2在致病突变的样本中表达显著降低,暗示其在下调基因表达中的潜在作用。免疫组织化学证实了致病性突变样品中蛋白表达的减少,巩固了我们的观察结果。Kaplan-Meier生存分析显示,与没有致病性BRCA1/2突变的患者相比,携带致病性BRCA1/2突变的患者的生存结果明显较差,强调了其在预后中的潜在作用。此外,KEGG通路分析强调了BRCA1/2参与关键的癌症相关通路,强调了它们在肿瘤发生中的作用。结论:我们的综合研究结果强调了BRCA1/2突变在胃癌中的临床意义,提倡进一步研究阐明其机制意义和治疗机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Detection of genomic variants in BRCA1 and BRCA2 across gastric cancer patients using next generation sequencing.

Objectives: To explore the landscape of BRCA1/2 mutations in gastric cancer patients.

Methods: Next-generation sequencing (NGS), Sanger sequencing, reverse transcription quantitative polymerase chain reaction (RT-qPCR), Immunohistochemistry, The Cancer Genome Atlas (TCGA), gnomAD, and DAVID.

Results: With 95% of bases boasting a phred score surpassing 30 and a minimum coverage depth of 500X, our NGS approach ensures high-quality data acquisition. Analyzing BRCA1 and BRCA2 sequences revealed 11 and 4 mutations, respectively, with one pathogenic mutation identified in each gene. This emphasizes the prominence of BRCA1 mutations in gastric cancer. Sanger sequencing validation confirmed the presence of pathogenic mutations in select cases, consolidating our findings. Frequency analysis utilizing the gnomAD database elucidated the rarity of these mutations in the Asian population, underscoring their uniqueness. Exploring TCGA data further corroborated this rarity, emphasizing the distinctive nature of these mutations in gastric cancer. RT-qPCR analysis unveiled a significant reduction in BRCA1/2 expression in samples harboring pathogenic mutations, hinting at their potential role in down-regulating gene expression. Immunohistochemistry confirmed diminished protein expression in samples with pathogenic mutations, solidifying our observations. Kaplan-Meier survival analysis demonstrated significantly poorer survival outcomes for patients with pathogenic BRCA1/2 mutations compared to those without, emphasizing their potential role in prognosis. Additionally, KEGG pathway analysis highlighted the involvement of BRCA1/2 in critical cancer-associated pathways, emphasizing their role in tumorigenesis.

Conclusion: Our comprehensive findings underscore the clinical significance of BRCA1/2 mutations in gastric cancer, advocating for further research to elucidate their mechanistic implications and therapeutic opportunities.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American journal of translational research
American journal of translational research ONCOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL
自引率
0.00%
发文量
552
期刊介绍: Information not localized
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信